We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Improving Efficiency in Drug Discovery and Preclinical Development

Creating and bringing new drugs to the market can bring huge productivity challenges as the already complex drug development process becomes lengthier and more expensive.

Using highly-validated commercially available biological reagents gives you the confidence that your results are right first time, increasing efficiency across your drug discovery and development workflows, and saving you valuable time and money.

Download this whitepaper to learn more about overcoming inefficiency challenges, enabling reproducible experiments and streamlining workflows by using high-quality biological reagents such as:

  • Recombinant monoclonal antibodies
  • Directly conjugated primary antibodies
  • High-throughput multiplex immunoassays